Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) EBITDA Margin (2016 - 2020)

Historic EBITDA Margin for Glucotrack (GCTK) over the last 7 years, with Q2 2020 value amounting to 617525.77%.

  • Glucotrack's EBITDA Margin fell 6167183500.0% to 617525.77% in Q2 2020 from the same period last year, while for Dec 2020 it was 123513.87%, marking a year-over-year decrease of 1252234900.0%. This contributed to the annual value of 1709.62% for FY2019, which is 170284700.0% up from last year.
  • Latest data reveals that Glucotrack reported EBITDA Margin of 617525.77% as of Q2 2020, which was down 6167183500.0% from 32888.68% recorded in Q1 2020.
  • Glucotrack's EBITDA Margin's 5-year high stood at 9599.1% during Q4 2019, with a 5-year trough of 617525.77% in Q2 2020.
  • For the 5-year period, Glucotrack's EBITDA Margin averaged around 45380.89%, with its median value being 2763.6% (2019).
  • Per our database at Business Quant, Glucotrack's EBITDA Margin skyrocketed by 162237800bps in 2018 and then crashed by 2000000000bps in 2020.
  • Over the past 5 years, Glucotrack's EBITDA Margin (Quarter) stood at 892.92% in 2016, then skyrocketed by 532bps to 3861.38% in 2017, then plummeted by -428bps to 12658.92% in 2018, then soared by 176bps to 9599.1% in 2019, then plummeted by -6533bps to 617525.77% in 2020.
  • Its last three reported values are 617525.77% in Q2 2020, 32888.68% for Q1 2020, and 9599.1% during Q4 2019.